Complete Genomics (GNOM) reverses late session gains to trade lower in the post session after reporting a Q4 loss of $0.67 per share, compared with the prior-year period's $0.69 loss per share. Revenues were $2.5M, down 34% from $3.8M in the same quarter last year. The Street was expecting a loss of $0.65 on revenues of $3.15M. Shares -2.1% AH.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Nov 26, 2012)
at MarketWatch.com (Oct 15, 2012)
at MarketWatch.com (Sep 17, 2012)
at Fox Business (Aug 31, 2012)
at MarketWatch.com (Jun 5, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs